Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Abdulhadi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Urology|March 1, 1993
Can citrate therapy prevent nephrolithiasis?M H Abdulhadi, P M Hall, S B Streem
Cleveland Clinic Journal of Medicine|May 1, 1988
Hypocitraturia and its role in renal stone diseaseM H Abdulhadi, P M Hall, S B Streem
ASAIO Transactions|July 1, 1989
Recombinant human erythropoietin correction of anemia. Dialysis efficiency, waste retention, and chronic dose variablesE P Paganini, M H Abdulhadi, J Garcia, et al.
ASAIO Transactions|July 1, 1989
Renal transplantation: results in hemodialysis patients previously treated with recombinant human erythropoietinE P Paganini, W E Braun, D Latham, et al.
Cleveland Clinic Journal of Medicine|September 1, 1987
Phenytoin toxicity: a cause of reversible monoplegiaM H Abdulhadi, D D Notman, G C Cardon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietinM H Abdulhadi, F M Fouad-Tarazi, T Thomas, et al.
Annals of Internal Medicine|December 15, 1989
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trialJ W Eschbach, M H Abdulhadi, J K Browne, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Urology|March 1, 1993
Can citrate therapy prevent nephrolithiasis?M H Abdulhadi, P M Hall, S B Streem
Cleveland Clinic Journal of Medicine|May 1, 1988
Hypocitraturia and its role in renal stone diseaseM H Abdulhadi, P M Hall, S B Streem
ASAIO Transactions|July 1, 1989
Recombinant human erythropoietin correction of anemia. Dialysis efficiency, waste retention, and chronic dose variablesE P Paganini, M H Abdulhadi, J Garcia, et al.
ASAIO Transactions|July 1, 1989
Renal transplantation: results in hemodialysis patients previously treated with recombinant human erythropoietinE P Paganini, W E Braun, D Latham, et al.
Cleveland Clinic Journal of Medicine|September 1, 1987
Phenytoin toxicity: a cause of reversible monoplegiaM H Abdulhadi, D D Notman, G C Cardon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietinM H Abdulhadi, F M Fouad-Tarazi, T Thomas, et al.
Annals of Internal Medicine|December 15, 1989
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trialJ W Eschbach, M H Abdulhadi, J K Browne, et al.
Pageof 1